Seeking catalyst driven opportunity
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Enliven Therapeutics Inc (Symbol: ELVN), where a total volume of 16,050 contracts has been traded thus far today, a contract volume which is representative of approximately 1.6 …
ImmunityBio IBRX enters the post-earnings stretch with the stock at $7.72 (as of May 28, 2026) and a six to12 month price target of $8.25. After a 289.9% year-to-date surge, the setup is less about “what’s next” and more about what has already been priced …
Key Points The Magnificent Seven tech stocks led the S&P 500 to enormous gains over the past few years as investors rushed into the latest growth opportunity: artificial intelligence (AI). Each of these players is involved in the technology at a certain level, offering investors …
Key Points Chip stocks such as Nvidia, Broadcom, and AMD have shown that their revenue and earnings are growing at incredible rates due to the huge amount of money being spent on AI data centers. TSMC is the go-to foundry partner for chip designers capitalizing …
Here’s a quick recap of the crypto landscape for Wednesday (May 27) as of 9:00 p.m. UTC. Get the latest insights on Bitcoin, Ether and altcoins, along with a round-up of key cryptocurrencymarket news Bitcoin (BTC) was priced at US$74,879.12, trading 1.1 percent lower over …
Key Points Some analysts think Apple is well-positioned to capitalize on agentic AI. The company’s deep ecosystem is an important reason it could do so. There are multiple reasons to buy the stock. 10 stocks we like better than Apple › Artificial intelligence (AI) helped …
Key Points Over the past 10 years, Microsoft stock has rarely been as cheap as it is now. Its updated agreement with OpenAI should add to its tailwinds. The latest update to the widely used Microsoft 365 suite is expected to noticeably boost the company’s …
ImmunityBio IBRX is building a portfolio of immunotherapies designed to activate both innate and adaptive immunity in cancer and infectious diseases. Its Cancer BioShield platform centers on Anktiva (nogapendekin alfa inbakicept), an interleukin-15 receptor superagonist antibody-cytokine fusion protein built to stimulate natural killer cells, cytotoxic …
In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, CrowdStrike Holdings Inc (Symbol: CRWD) has taken over the #72 spot from Netflix Inc (Symbol: NFLX), according to ETF Channel. Below is a chart of CrowdStrike Holdings …
Key Points Ford’s price-to-earnings ratio of 11.3 supports a hefty dividend yield of more than 4%. As a mass-market carmaker, this company is characterized by low growth and weak profits. The automotive stock’s long-term shareholder track record doesn’t provide a reason to be optimistic. 10 …